Tomorrow's Panel ➡️ Patient Stories Without a Fixed Address


Hi!

A quick reminder that tomorrow is our inaugural PA&E Roundtable event.

Wherever the patient advocacy function formally sits in an organization research, communicators are often the ones helping translate those patient insights into stories that resonate internally and externally.

Tomorrow’s conversation will explore how teams gather those insights, how communicators partner across functions, and what it takes to represent patient experiences thoughtfully and responsibly in our work. The discussion will draw on the real-world perspectives and examples our panelists have encountered across their careers.

Patient Stories Without a Fixed Address

📅 Thursday, March 5th (tomorrow)

🕛 12-1 p.m. ET / 9-10 a.m. PT / 5-6 p.m. GMT

Sign up here.​

Exclusive to T2B Pro and Student members

What we’ll cover

  • Ways teams collect and learn from patient insights and stories
  • Approaches for representing patient experiences authentically within organizational guardrails
  • Real examples where patient stories shaped communications strategies or campaigns
  • How communicators collaborate with advocacy, medical, research, and commercial colleagues

Featured speakers

💬 Rebecca Cowens-Alvarado, Director, U.S. Advocacy Relations, Oncology, Bayer
💬 Stephanie Kenney, Chief Corporate Affairs Officer, Atrium Therapeutics
💬 Dr. Anthony Yanni, Founder & CEO, Lucid Health Solutions (former Global Head of Patient Centricity at Astellas)

Moderated by Jeff Sears, Global Head, Strategy & Operations, Communications & Investor Relations, Astellas U.S., and T2B PA&E Roundtable member

We hope you’ll join us for the first of what we intend to be many conversations led by our Patient Advocacy & Engagement Roundtable!

Lynnea

P.S. - If you're not a T2B Pro member, please consider upgrading here to join tomorrow's panel and all our other roundtable-led programming (like press panels, AI webinars, and our upcoming event on ESG).

T2B Monthly

Read more from T2B Monthly

Hi! At our February Comm Convo, Fighting Misinformation Without Amplifying It, we examined the practical reality biopharma communicators navigate every day: A fast-moving information environment where incomplete, misleading, or distorted claims can gain traction quickly. There is rarely a clean or standard how-to for responding when misinformation spreads. Instead, effective responses depend on preparation, cross-functional alignment, and disciplined judgment about when engagement adds...

Hi! As we know all too well, life sciences comms comes with a unique set of complexities, from regulatory constraints, to deep investor scrutiny, to audiences with technical expectations. But many of the challenges we face aren’t truly one-of-a-kind to our sector. Across industries, communicators wrestle with trust, ambiguity, executive counsel under pressure, and shifting stakeholder dynamics. Our March Comm Convo brings together communicators who have worked in and out of life sciences to...

T2B Monthly | February 2026 Hi! Even though we always ask our panelists to ditch the BS, even I'm sometimes surprised by the candor that shows up. Across our Post-JPM press panel, Beyond ChatGPT webinar this morning, and Navigating Misinformation Comm Convo, this month was no exception. I also want to shout out our roundtables. Member-led, volunteer-driven, diving deep into the disciplines that make up our world. They are setting a high bar. Seriously. Someone called T2B a "movement" the...